BCIQ Profiles

Company Profile Report
0526 NiKang Crossovers
BioCentury & Getty Images

Finance

Building on discovery platform and early deals, CBC-backed NiKang adds $200M in crossover series C round

With backing from high-profile crossover investors, four-year-old company taking wholly-owned HIF2A program into clinic

With backing from high-profile crossover investors, four-year-old company taking wholly-owned HIF2A program into clinic.

May 26, 2021 | 10:26 PM GMT

Crossover firms led by Bihua Chen’s Cormorant, Swiss investor HBM and Ting Jia’s

Read the full 661 word article

How to gain access

Continue reading with a
two-week free trial.